Billionaire Profile
I
Global Rank
#602

Image: Towner, Isabel L., Comp. | Public domain | via Wikimedia Commons

Isabel Boehringer

CEO, Pharmaceuticals
GERMANY
Real-Time Net Worth
$6.636B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
45
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
GERMANY

Biography

Isabel Boehringer, at 45 years old, is a prominent figure in the pharmaceutical industry, deriving her wealth from Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. Her estimated net worth is $6.6 billion. Boehringer is part of the Boehringer family, who founded the company in 1885. Today, the company employs over 54,000 people across 130 markets. Boehringer Ingelheim's focus on research and development has led to numerous advancements in human and animal health, with a strong pipeline and investments in key areas like oncology and cardiovascular health.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Isabel Boehringer is part of the Boehringer family, who founded Boehringer Ingelheim in 1885 in Ingelheim am Rhein, Germany. The company started producing ingredients for pharmacies, textile merchants, and the food industry.

Rise to Success

Boehringer's wealth stems from her ownership stake in Boehringer Ingelheim, a global pharmaceutical giant. The company has grown to employ over 54,000 people and has a presence in 130 markets. The company's focus is on research and development, with substantial investments in new treatments, and is recognized as a top pharmaceutical company.

Key Business Strategies

Boehringer Ingelheim's success is rooted in its commitment to innovation, long-term sustainable action, and focus on research and development. The company is not publicly traded, which allows it to focus on long-term goals rather than quarterly earnings expectations. The company invests heavily in R&D, allocating approximately 23.2% of its net sales to this area in 2024. The company has a strong presence in key markets like North America, Europe, and Asia.

Philanthropy

Boehringer Ingelheim has a Cares Foundation that supports programs focused on improving healthcare access, enhancing STEM education, and strengthening the human-animal bond. Since 2001, the foundation has donated over $37 million to programs aligned with its goals.

Philanthropy & Social Impact

Healthcare, Education, Animal Welfare

Boehringer Ingelheim Cares Foundation

$37M+

Donations to programs aligned with healthcare access, STEM education, and strengthening the human-animal bond since 2001